| |
| |
|
| Insider
Information: |
Denner Alexander J |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
113,563 |
|
|
Indirect Shares
|
18,606,943 |
|
|
| Direct
Value |
$3,642,667 |
|
|
|
Indirect Value
|
$241,895,601 |
|
|
| Total
Shares |
18,720,506 |
|
|
| Total
Value |
$245,538,268 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
18
|
0
|
|
Stock
price went up :
|
18
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
18.0
|
0.0
|
| Percentage
Gain/Loss : |
 124.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Director |
2022-06-15 |
15,099 |
2022-06-15 |
643,000 |
Premium* |
|
|
Enzon Pharmaceuticals Inc |
ENZN |
Director |
2012-07-02 |
60,620 |
2009-05-21 |
0 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2012-08-08 |
0 |
2011-05-24 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-11-08 |
0 |
2013-11-11 |
2,573,943 |
Premium* |
|
|
Ariad Pharmaceuticals Inc |
ARIA |
Director |
2017-02-16 |
0 |
2017-02-16 |
0 |
Premium* |
|
|
Bioverativ Inc. |
BIVV |
Director |
2018-03-08 |
0 |
2018-03-08 |
0 |
Premium* |
|
|
Ironwood Pharmaceuticals Inc |
IRWD |
Director |
2021-03-02 |
37,844 |
2021-03-02 |
15,390,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2015-10-23 |
4 |
B |
$276.77 |
$27,677,000 |
I/I |
100,000 |
310,000 |
2.1 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Director |
• • – |
2016-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
35,165 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,060 |
8,950 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Director |
– • – |
2017-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
18,008 |
53,173 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Director |
– • – |
2017-02-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,850,000) |
0 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Director |
– • – |
2017-02-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(53,173) |
0 |
0 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
• • – |
2017-04-17 |
4 |
A |
$56.83 |
$60,012 |
D/D |
1,056 |
5,001 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2017-04-27 |
4 |
B |
$278.48 |
$20,569,476 |
I/I |
73,858 |
383,858 |
2.1 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
• • – |
2017-05-24 |
4 |
B |
$54.16 |
$18,414,400 |
I/I |
340,000 |
495,000 |
2.1 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
• • – |
2017-05-25 |
4 |
B |
$54.98 |
$7,147,907 |
I/I |
130,000 |
625,000 |
2.1 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
• • – |
2017-05-26 |
4 |
B |
$57.21 |
$25,745,130 |
I/I |
450,000 |
1,075,000 |
2.1 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
• • – |
2017-05-30 |
4 |
B |
$55.93 |
$5,033,475 |
I/I |
90,000 |
1,165,000 |
2.66 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2017-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,055 |
10,029 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2017-08-31 |
4 |
A |
$316.56 |
$295,350 |
I/I |
933 |
383,858 |
0 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
– • – |
2017-08-31 |
4 |
A |
$56.69 |
$52,835 |
I/I |
932 |
1,165,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2017-11-28 |
4 |
B |
$316.12 |
$6,322,400 |
I/I |
20,000 |
403,858 |
2.1 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2017-11-29 |
4 |
B |
$319.84 |
$3,198,400 |
I/I |
10,000 |
413,858 |
2.1 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
• • – |
2018-03-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,001) |
0 |
0 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
• • – |
2018-03-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,165,000) |
0 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2018-04-25 |
4 |
B |
$269.91 |
$12,955,680 |
I/I |
48,000 |
461,858 |
2.1 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
880 |
10,909 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2019-01-30 |
4 |
B |
$324.86 |
$9,745,851 |
I/I |
30,000 |
491,858 |
2.1 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2019-01-31 |
4 |
B |
$330.52 |
$8,527,393 |
I/I |
25,800 |
517,658 |
2.1 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2019-02-01 |
4 |
B |
$328.45 |
$2,299,163 |
I/I |
7,000 |
524,658 |
2.1 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2019-04-30 |
4 |
B |
$229.25 |
$11,540,904 |
I/I |
50,342 |
575,000 |
2.1 |
- |
|
61 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
